Granules India Limited
GRANULES · 532482 · Healthcare · Pharmaceuticals
- Market cap
- Rs 20,750 Cr
- P/E
- 30.94x
- P/B
- 4.08x
- 52W high / low
- Rs 923.65 / Rs 529.85
About Granules India
Granules India Limited is listed on the NSE under the symbol GRANULES and on the BSE under scrip code 532482. It is classified in the Healthcare sector, industry: Pharmaceuticals. It is a constituent of BSE 500, NIFTY 500 and NIFTY Smallcap 250. The company listed on 20 Jun 2005 and has a face value of Rs 1.
The latest available end-of-day price is Rs 837.35 (−0.37% on the day), for a market capitalisation of Rs 20,750 Cr. Trailing P/E is 30.94x and price-to-book is 4.08x. The 52-week range is Rs 529.85 to Rs 923.65. The latest price is 78% of the way from the 52-week low to the 52-week high.
Against the 16-company comparison set from the official BSE basic industry Pharmaceuticals, its market capitalisation is 0.2 times the peer median of Rs 93,249 Cr, and its P/E of 30.94x compares with a peer median of 37.31x. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For Q1 FY27 (period ended 30 Jun 2026), Granules India Limited reported revenue of Rs 1,477 Cr, net profit of Rs 180 Cr and earnings per share of Rs 7.26.
On a trailing-twelve-month basis the filings add up to revenue of Rs 5,632 Cr, net income of Rs 662 Cr and a net margin of 11.76%.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Torrent Pharmaceuticals Limited | Rs 4,580 | Rs 1,55,015 Cr | Rs 15,654 Cr | Rs 2,156 Cr | 73.16x | 27.30% |
| Laurus Labs Limited | Rs 2,244 | Rs 1,21,232 Cr | Rs 7,323 Cr | Rs 1,091 Cr | — | 22.38% |
| Zydus Lifesciences Limited | Rs 1,184.4 | Rs 1,18,203 Cr | Rs 29,052 Cr | Rs 4,593 Cr | 26.40x | 17.68% |
| Dr. Reddy's Laboratories Limited | Rs 1,345 | Rs 1,12,308 Cr | Rs 34,353 Cr | Rs 2,760 Cr | 40.02x | 7.84% |
| Cipla Limited | Rs 1,358 | Rs 1,09,706 Cr | Rs 28,855 Cr | Rs 2,854 Cr | 37.86x | 8.83% |
| Mankind Pharma Limited | Rs 2,469.3 | Rs 1,01,982 Cr | Rs 15,705 Cr | Rs 2,264 Cr | 45.45x | 14.78% |
| Aurobindo Pharma Limited | Rs 1,659.9 | Rs 95,511 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 25.94x | 10.53% |
| Lupin Limited | Rs 1,989.9 | Rs 90,988 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 16.44x | 27.89% |
| Glenmark Pharmaceuticals Limited | Rs 2,339 | Rs 66,007 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 36.71x | 15.46% |
| Alkem Laboratories Limited | Rs 5,079 | Rs 60,719 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 28.15x | 16.72% |
| Biocon Limited | Rs 351.9 | Rs 57,346 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Abbott India Limited | Rs 26,145 | Rs 55,558 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 34.41x | 35.85% |
| Gland Pharma Limited | Rs 3,074.5 | Rs 50,717 Cr | Rs 7,045 Cr | Rs 1,129 Cr | 44.88x | 11.57% |
| IPCA Laboratories Limited | Rs 1,926.2 | Rs 48,868 Cr | Rs 10,293 Cr | Rs 1,375 Cr | 37.31x | 17.45% |
| Ajanta Pharma Limited | Rs 3,459.7 | Rs 43,367 Cr | Rs 5,993 Cr | Rs 1,135 Cr | 38.09x | 27.19% |
| Granules India LimitedThis company | Rs 837.35 | Rs 20,750 Cr | Rs 5,639 Cr | Rs 662 Cr | 30.94x | 15.05% |
| Median | Rs 2,116.95 | Rs 93,249 Cr | Rs 15,667 Cr | Rs 2,180 Cr | 37.31x | 17.09% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to Granules India
Same official industry (Pharmaceuticals)
- Torrent Pharmaceuticals LimitedTORNTPHARM · Market cap Rs 1,55,015 Cr
- Laurus Labs LimitedLAURUSLABS · Market cap Rs 1,21,232 Cr
- Zydus Lifesciences LimitedZYDUSLIFE · Market cap Rs 1,18,203 Cr
- Dr. Reddy's Laboratories LimitedDRREDDY · Market cap Rs 1,12,308 Cr
- Cipla LimitedCIPLA · Market cap Rs 1,09,706 Cr
- Mankind Pharma LimitedMANKIND · Market cap Rs 1,01,982 Cr
- Aurobindo Pharma LimitedAUROPHARMA · Market cap Rs 95,511 Cr
- Lupin LimitedLUPIN · Market cap Rs 90,988 Cr
Other Healthcare companies of a similar market capitalisation
- Neuland Laboratories LimitedNEULANDLAB · Market cap Rs 24,872 Cr
- Cohance Lifesciences LimitedCOHANCE · Market cap Rs 18,416 Cr
- Caplin Point Laboratories LimitedCAPLIPOINT · Market cap Rs 18,058 Cr
- Onesource Specialty Pharma LimitedONESOURCE · Market cap Rs 17,994 Cr
- Pfizer LimitedPFIZER · Market cap Rs 17,201 Cr
- Eris Lifesciences LimitedERIS · Market cap Rs 16,139 Cr
- Syngene International LimitedSYNGENE · Market cap Rs 16,091 Cr
- Vijaya Diagnostic Centre LimitedVIJAYA · Market cap Rs 15,066 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.